Salvatore Fiorenza

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL”.

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL

Blood Advances(2025)10.1182/bloodadvances.2024015314

N/A

0.447DataRank · unranked

10 citations

Emily C. Liang, Jennifer J. Huang, Erik L. Kimble, Alexandre V. Hirayama, Salvatore Fiorenza +15 more

Multicenter prospective study on predictors of short-term outcome in disorders of consciousness

Neurology(2020)10.1212/wnl.0000000000010254

N/A

0DataRank · unranked

106 citations

Salvatore Fiorenza, Alfonso Magliacano, Rita Formisano, Donatella Mattia, Antonello Grippo +27 more

Risk factors for 2‐year mortality in patients with prolonged disorders of consciousness: An international multicentre study

European Journal of Neurology(2021)10.1111/ene.15143

N/A

0DataRank · unranked

41 citations

Alfonso Magliacano, Salvatore Fiorenza, Rita Formisano, Antonello Grippo, Efthymios Angelakis +17 more